Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial
2020 · The Lancet Oncology · 625 citations
https://doi.org/10.1016/s1470-2045(20)30011-5
W
Weijia Fang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
258
Papers
8.1K
Citations
42
h-index
94
i10-index
Weijia Fang is an academic researcher from First Affiliated Hospital Zhejiang University. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Colorectal Cancer Treatments and Studies & Pancreatic and Hepatic Oncology Research. The author has an h-index of 42, co-authored 220 publications.
ORCID: 0000-0001-9849-347XPapers by this author
worksCamrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study
2023 · The Lancet · 590 citations
https://doi.org/10.1016/s0140-6736(23)00961-3
Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
2021 · The Lancet. Gastroenterology & hepatology · 243 citations
https://doi.org/10.1016/s2468-1253(21)00109-6
Reactive cutaneous capillary endothelial proliferation in advanced hepatocellular carcinoma patients treated with camrelizumab: data derived from a multicenter phase 2 trial
2020 · Journal of Hematology & Oncology · 132 citations
https://doi.org/10.1186/s13045-020-00886-2
Construction of TME and Identification of crosstalk between malignant cells and macrophages by SPP1 in hepatocellular carcinoma
2021 · Cancer Immunology Immunotherapy · 124 citations
https://doi.org/10.1007/s00262-021-02967-8
Over-expression of cathepsin B in hepatocellular carcinomas predicts poor prognosis of HCC patients
2016 · Molecular Cancer · 100 citations
https://doi.org/10.1186/s12943-016-0503-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat